Fluconazole downregulates metallothionein expression and increases copper cytotoxicity in Microsporum canis

Biochem Biophys Res Commun. 2002 Dec 20;299(5):688-92. doi: 10.1016/s0006-291x(02)02724-9.

Abstract

Azole antifungals are widely used to treat infections with dermatophyte fungi. Whereas it is well established that this class of drugs interferes with fungal ergosterol synthesis, little is known about its potential other biological effects. Here we report the isolation and structural organization of Microsporum canis metallothionein gene and demonstrate that fluconazole is able to downregulate the baseline as well as copper-induced expression of this gene. Since this effect occurred within 30 min after exposure of the fungus to fluconazole, it is unlikely that it is due to impaired ergosterol synthesis. Our additional demonstration that fluconazole enhances copper toxicity for M. canis suggests that inhibition of metallothionein expression by fluconazole is biologically relevant and may represent an important additional mode of the antifungal action of this drug. Therefore our data indicate that antifungal effects of azole derivatives might not only be due to interference with cell wall synthesis but may also affect other biological circuits within the fungal cells.

MeSH terms

  • Amino Acid Sequence
  • Antifungal Agents / pharmacology*
  • Base Sequence
  • Cell Division / drug effects
  • Copper / toxicity*
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Drug Synergism
  • Fluconazole / pharmacology*
  • Gene Expression Regulation, Fungal / drug effects*
  • Metallothionein / genetics
  • Metallothionein / metabolism*
  • Microsporum / drug effects*
  • Microsporum / genetics
  • Microsporum / metabolism
  • Molecular Sequence Data
  • RNA, Messenger / biosynthesis
  • Sequence Alignment

Substances

  • Antifungal Agents
  • RNA, Messenger
  • Copper
  • Fluconazole
  • Metallothionein

Associated data

  • GENBANK/AF408429